500
Views
7
CrossRef citations to date
0
Altmetric
Review

Topical drug delivery to the retina: obstacles and routes to success

Pages 9-21 | Received 06 Aug 2021, Accepted 09 Dec 2021, Published online: 31 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ya-Chun Chu, Hsu-Wei Fang, Yu-Yi Wu, Yu-Jun Tang, Erh-Hsuan Hsieh, YiZhou She, Che-Yi Chang, I-Chan Lin, Yin-Ju Chen, Guei-Sheung Liu & Ching-Li Tseng. (2023) Functional Peptide-Loaded Gelatin Nanoparticles as Eyedrops for Cornea Neovascularization Treatment. International Journal of Nanomedicine 18, pages 1413-1431.
Read now

Articles from other publishers (6)

Xiaolin Li, Xunchan Jiang, Xiaolei Zhou, Yanju Cheng & Feng Cao. (2023) Development of dexamethasone suspension eye drops: A comparative investigation of ternary and quaternary cyclodextrin aggregates. Journal of Drug Delivery Science and Technology 82, pages 104383.
Crossref
Thorsteinn Loftsson & Einar Stefánsson. (2023) Topical dexamethasone delivery to the retina: An aqueous cyclodextrin-based microsuspension. Journal of Drug Delivery Science and Technology 81, pages 104281.
Crossref
Yun-Yi Cong, Bin Fan, Zi-Yuan Zhang & Guang-Yu Li. (2023) Implantable sustained-release drug delivery systems: a revolution for ocular therapeutics. International Ophthalmology 43:7, pages 2575-2588.
Crossref
Juber Akhtar & Badruddeen. 2022. Drug Development Life Cycle. Drug Development Life Cycle.
Tianyang Liu, Nkiruka Ibeanu, Steve Brocchini, Peng Tee Khaw, Yann Bouremel & Sahar Awwad. (2022) Development of an in vitro model to estimate mass transfer from the anterior cavity. Frontiers in Drug Delivery 2.
Crossref
Phatsawee Jansook & Thorsteinn Loftsson. (2022) Aqueous Prostaglandin Eye Drop Formulations. Pharmaceutics 14:10, pages 2142.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.